| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |